Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$10.00 – $11.51
100% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $349.40B | $347.52B | $355.35B | $366.23B | $389.87B | $402.77B | $412.94B | $422.46B |
| Cost of revenue | $177.67B | $175.59B | $175.48B | $187.13B | $215.26B | $222.17B | $224.16B | $228.37B |
| Gross profit | $171.73B | $171.93B | $179.87B | $179.10B | $174.61B | $180.60B | $188.78B | $194.09B |
| Gross margin | 49.1% | 49.5% | 50.6% | 48.9% | 44.8% | 44.8% | 45.7% | 45.9% |
| R&D | $10.97B | $10.94B | $10.91B | $11.18B | $11.08B | $0 | $0 | $11.93B |
| Operating income | $34.20B | $29.83B | $44.07B | $31.18B | $28.84B | $20.13B | $28.39B | $30.79B |
| EBITDA | $37.75B | $42.07B | $48.60B | $46.06B | $42.40B | $43.42B | $54.22B | $51.93B |
| Net income | $25.61B | $20.56B | $29.87B | $23.76B | $21.94B | $14.62B | $21.20B | $27.61B |
| Net margin | 7.3% | 5.9% | 8.4% | 6.5% | 5.6% | 3.6% | 5.1% | 6.5% |
| EPS (diluted) | 87.99 | 70.63 | 102.61 | 81.59 | 76.91 | 51.35 | 76.41 | 99.64 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $435.3B | $92.75 | $90.15–$97.79 | 1 |
| 2027 | $440.5B | $94.81 | $92.15–$99.96 | 1 |
| 2028 | $452.4B | $103.82 | $100.91–$109.46 | 1 |
| 2029 | $465.9B | $112.84 | $109.68–$118.97 | 1 |
Forward consensus · source: Financial Modeling Prep
LION CORP
No one on the platform currently holds LIOPF.
No tracked institution reports a position in LIOPF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-12-31 | $17.0000 | |
| 2026-06-30 | $17.0000 | |
| 2025-12-31 | $15.0000 | 2026-03-05 |
| 2025-06-30 | $15.0000 | 2025-09-02 |
| 2024-12-31 | $14.0000 | 2025-03-06 |
| 2024-06-28 | $13.0000 | 2024-09-04 |
| 2023-12-29 | $13.0000 | 2024-03-07 |
No one on the platform has traded LIOPF yet.
| $2.9B |
| — |
| KBYPFKobayashi Pharmaceutical Co., Ltd. | $34.05 | +0.00% | $2.5B | — |
| LYSFFLeroy Seafood Group ASA | $4.24 | +0.00% | $2.5B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.